Concepedia

J. Brookes

JB

Statistics

Publications

3

Citations

486

H-Index

3

Active since

2020

Affiliations

Synairgen (United Kingdom)(Current)

NIHR Southampton Biomedical Research Centre

University of Southampton

Hull York Medical School

University of Hull

J. Brookes is an author at Synairgen (United Kingdom) specializing in antiviral therapy, infectious diseases, and interferon-based therapy.

Publications per year

2020–2024

3

Publications

3

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Phillip Monk, Richard Marsden, Victoria Tear et al. · The Lancet Respiratory Medicine · 2020 · 455 citations · Full text

, , +10

Nebulised interferon-β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III study

Phillip Monk, J. Brookes, Victoria Tear et al. · ERJ Open Research · 2022 · 20 citations · Full text

, , +17

Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD

Phillip Monk, J. Brookes, Victoria Tear et al. · Respiratory Research · 2024 · 11 citations · Full text

, , +17

1–3 of 3